UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease

PLoS biology, 2022-07, Vol.20 (7), p.e3001709-e3001709

2022

Volltextzugriff (PDF)

Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies

PLoS pathogens, 2012-04, Vol.8 (4), p.e1002634-e1002634

2012

Volltextzugriff (PDF)

Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report

BMC infectious diseases, 2021-03, Vol.21 (1), p.298-298, Article 298

2021

Volltextzugriff (PDF)

Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response

The Journal of clinical investigation, 2022-06, Vol.132 (12), p.1-16

2022

Volltextzugriff (PDF)

Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona

Swiss medical weekly, 2021-11, Vol.151 (4546), p.w30092

2021

Volltextzugriff (PDF)

Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022

Swiss medical weekly, 2023-12, Vol.153 (12), p.3502

2023

Volltextzugriff (PDF)

Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study

International journal of public health, 2020-12, Vol.65 (9), p.1549-1557

2020

Volltextzugriff (PDF)

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1

The Journal of experimental medicine, 2011-03, Vol.208 (3), p.439-454

2011

Volltextzugriff (PDF)

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection

mBio, 2024-02, Vol.15 (2), p.e0272223-e0272223

2024

Volltextzugriff (PDF)

Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office

Antimicrobial resistance & infection control, 2020-12, Vol.9 (1), p.191-191, Article 191

2020

Volltextzugriff (PDF)

Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines

Cell reports. Medicine, 2024-09, Vol.5 (9), p.101702, Article 101702

2024

Volltextzugriff (PDF)

Therapeutic antibodies in HIV treatment--classical approaches to novel advances

Current pharmaceutical design, 2010-11, Vol.16 (33), p.3754-3766

2010

Volltextzugriff (PDF)

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA

Rheumatic & musculoskeletal diseases open, 2022-10, Vol.8 (2), p.e002575

2022

Volltextzugriff (PDF)

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools

BMJ (Online), 2021-03, Vol.372 (Art. n616), p.o.A.-372:Art. n616

2021

Volltextzugriff (PDF)

Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series

Stroke (1970), 2020-12, Vol.51 (12), p.3719-3722

2020

Volltextzugriff (PDF)

Alpha Variant Coronavirus Outbreak in a Nursing Home Despite High Vaccination Coverage: Molecular, Epidemiological, and Immunological Studies

Clinical infectious diseases, 2023-08, Vol.77 (4), p.537-546

2023

Volltextzugriff (PDF)

Correlates of broadly neutralizing antibody development

Current opinion in HIV & AIDS, 2019-07, Vol.14 (4), p.279-285

2019

Volltextzugriff (PDF)

Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID‐19 prevention

British journal of haematology, 2024-05, Vol.204 (5), p.1908-1912

2024

Volltextzugriff (PDF)

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study

Journal of acquired immune deficiency syndromes (1999), 2022-12, Vol.91 (5), p.508-515

2022

Volltextzugriff (PDF)

B‐cell maturation antigen‐directed bispecific antibodies in plasmablastic lymphoma

British journal of haematology, 2024-08, Vol.205 (2), p.722-725

2024

Volltextzugriff (PDF)

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity

The Journal of infectious diseases, 2023-10, Vol.228 (8), p.1042-1054

2023

Volltextzugriff (PDF)

Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1

AIDS (London), 2024-02, Vol.38 (2), p.217-222

2024

Volltextzugriff (PDF)

Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?

Journal of acquired immune deficiency syndromes (1999), 2023-04, Vol.92 (5), p.399-404

2023

Volltextzugriff (PDF)

Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV

AIDS (London), 2022-08, Vol.36 (10), p.1465-1468

2022

Volltextzugriff (PDF)

1 – 25 von 68

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(66)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(68)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(56)
Life Sciences & Biomedicine
(52)
Humans
(37)
Infectious Diseases
(24)
Immunology
(20)
Severe Acute Respiratory Syndrome Coronavirus 2
(16)
Covid-19
(15)
Hiv
(14)
Sars-Cov-2
(14)
Female
(13)
Coronaviruses
(12)
Cohort Studies
(11)
Human Immunodeficiency Virus
(11)
Male
(11)
Microbiology
(11)
Risk Factors
(11)
Adult
(9)
Child
(9)
Hiv Infections - Drug Therapy
(9)
Infections
(9)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(2)
... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

Critically ill COVID-19 patients with neutralizing autoantibodies against type I interferons have increased risk of herpesvirus disease

Cell-cell transmission enables HIV-1 to evade inhibition by potent CD4bs directed antibodies

Subacute cerebellar ataxia following respiratory symptoms of COVID-19: a case report

Multifactorial seroprofiling dissects the contribution of pre-existing human coronaviruses responses to SARS-CoV-2 immunity

Antibodies from convalescent plasma promote SARS-CoV-2 clearance in individuals with and without endogenous antibody response

Evolution of SARS-CoV-2 seroprevalence and clusters in school children from June 2020 to April 2021: prospective cohort study Ciao Corona

Long-term course of neutralising antibodies against SARS-CoV-2 in vaccinated and unvaccinated staff and residents in a Swiss nursing home: a cohort study 2021-2022

Seroprevalence and immunity of SARS-CoV-2 infection in children and adolescents in schools in Switzerland: design for a longitudinal, school-based prospective cohort study

MPER-specific antibodies induce gp120 shedding and irreversibly neutralize HIV-1

Cross-protective HCoV immunity reduces symptom development during SARS-CoV-2 infection

Does respiratory co-infection facilitate dispersal of SARS-CoV-2? investigation of a super-spreading event in an open-space office

Decoupling HIV-1 antiretroviral drug inhibition from plasma antibody activity to evaluate broadly neutralizing antibody therapeutics and vaccines

Therapeutic antibodies in HIV treatment--classical approaches to novel advances

Postvaccination anti-S IgG levels predict anti-SARS-CoV-2 neutralising activity over 24 weeks in patients with RA

Clustering and longitudinal change in SARS-CoV-2 seroprevalence in school children in the canton of Zurich, Switzerland: prospective cohort study of 55 schools

Large and Small Cerebral Vessel Involvement in Severe COVID-19: Detailed Clinical Workup of a Case Series

Alpha Variant Coronavirus Outbreak in a Nursing Home Despite High Vaccination Coverage: Molecular, Epidemiological, and Immunological Studies

Correlates of broadly neutralizing antibody development

Evaluating tixagevimab/cilgavimab prophylaxis in allogeneic haematopoietic cell transplantation recipients for COVID‐19 prevention

CD4:CD8 Ratio and CD8 Cell Count and Their Prognostic Relevance for Coronary Heart Disease Events and Stroke in Antiretroviral Treated Individuals: The Swiss HIV Cohort Study

B‐cell maturation antigen‐directed bispecific antibodies in plasmablastic lymphoma

Seroprofiling of Antibodies Against Endemic Human Coronaviruses and Severe Acute Respiratory Syndrome Coronavirus 2 in a Human Immunodeficiency Virus Cohort in Lesotho: Correlates of Antibody Response and Seropositivity

Bridging the gap: identifying factors impacting mRNA severe acute respiratory syndrome coronavirus 2 vaccine booster response in people with HIV-1

Brief Report: Does Menopause Transition Influence Viral Suppression and Adherence in Women Living With HIV?

Determinants of antibody response to severe acute respiratory syndrome coronavirus 2 mRNA vaccines in people with HIV

Suchergebnisse filtern